Clinical Trial: A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Myeloid Leukaemia
Study Type: INTERVENTIONAL
Official Title: A Phase I, Single-arm, Open Label, Dose Escalation, Multicenter Study of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/
Brief Summary:
This is a single group, Phase 1, single-arm, dose escalation study to determine the candidate dose(s), and evaluate safety, tolerability, and preliminary anti-tumor activity of SAR445419 administered after fludarabine and cytarabine conditioning for the treatment of relapsed or refractory acute myeloid leukemia (R/R AML).Adult participants with R/R AML will be eligible for treatment.The study is intended to assess the candidate dose(s) by the occurrence of dose-limiting toxicity (DLT) from start of…
Read more